Model Predicts Acute GI Bleeding in Anticoagulated Patients

This article originally appeared here.
Share this content:
Model Predicts Acute GI Bleeding in Anticoagulated Patients
Model Predicts Acute GI Bleeding in Anticoagulated Patients

FRIDAY, June 2, 2017 (HealthDay News) -- For patients taking oral anticoagulants, a new model can predict acute gastrointestinal (GI) bleeding, which is associated with increased risk of all-cause mortality, according to a study published online May 19 in the Journal of Gastroenterology and Hepatology.

Akira Shimomura, M.D., from the National Center for Global Health and Medicine in Tokyo, and colleagues followed a cohort of 508 patients taking oral anticoagulants (66 direct oral anticoagulant users and 442 warfarin users). The authors developed the bleeding model by multivariate survival analysis.

The researchers noted 42 GI bleeds (8.3 percent) during a median follow-up of 31.4 months: 42.8, 50.0, and 7.1 percent in the upper, lower, and middle GI tract, respectively. The cumulative five-year probability of bleeding was 12.6 percent, while the 10-year probability was 18.5 percent. The cumulative incidence of all-cause mortality was significantly higher for patients who bled (hazard ratio, 2.9). GI bleeding was predicted by absence of proton pump inhibitor therapy, chronic kidney disease, chronic obstructive pulmonary disease, history of peptic ulcer disease, and liver cirrhosis, in multivariate analysis. Using these five factors, the C-statistic for the new predictive model was 0.65, which was higher than the HAS-BLED score of 0.57.

"Gastrointestinal bleeding increased the risk of subsequent mortality during follow-up of anticoagulated patients, highlighting the importance of prevention," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »